India to United States: Imatinib Export Trade Route
India has recorded 117 verified shipments of Imatinib exported to United States, representing a combined trade value of $5.3M USD. This corridor is served by 11 active Indian exporters, with an average shipment value of $45.5K USD. The leading Indian exporter is EUGIA PHARMA SPECIALITIES LIMITED, which accounts for 85% of total export value with 60 shipments worth $4.6M USD. On the buying side, AUROBINDO PHARMA USA INC is the largest importer in United States with $1.5M USD in purchases. The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Imatinib corridor is one of India's established pharmaceutical export routes, with 117 shipments documented worth a combined $5.3M USD. The route is dominated by EUGIA PHARMA SPECIALITIES LIMITED, which alone accounts for roughly 85% of all export value, reflecting the consolidated nature of India's imatinib manufacturing sector.
Across 11 active suppliers, the average shipment value stands at $45.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with imatinib's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 13.9%, placing it at rank #20 among India's top imatinib export destinations globally.
On the import side, key buyers of Indian imatinib in United States include AUROBINDO PHARMA USA INC, AUROBINDO PHARMA USA., INC,, QUALLENT PHARMACEUTICALS HEALTH LLC and 22 others. AUROBINDO PHARMA USA INC is the single largest importer with 14 shipments valued at $1.5M USD.
Route Characteristics
- Average transit25 days
- Peak seasonQ1
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#20
- Annual growth+13.9%
- Demand growth+14.0%
- Regulatory ease72/100
Top 10 Indian Imatinib Exporters to United States
Showing top 10 of 11 Indian suppliers exporting Imatinib to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EUGIA PHARMA SPECIALITIES LIMITED Avg $75.8K per shipment | 60 | $4.6M | 85.4% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $19.3K per shipment | 31 | $597.4K | 11.2% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LTD Avg $42.6K per shipment | 4 | $170.3K | 3.2% |
| 4 | MYGENIC HEALTHCARE PRIVATE LIMITED Avg $1.5K per shipment | 3 | $4.4K | 0.1% |
| 5 | KOIT BIOPHARMA PRIVATE LIMITED Avg $782 per shipment | 3 | $2.3K | 0.0% |
| 6 | ATLAS ENTERPRISES Avg $356 per shipment | 6 | $2.1K | 0.0% |
| 7 | VEA IMPEX (I) PRIVATE LIMITED Avg $388 per shipment | 2 | $777 | 0.0% |
| 8 | VEA IMPEX I PRIVATE LIMITED Avg $83 per shipment | 5 | $417 | 0.0% |
| 9 | VINAYAK ASSOCIATES Avg $191 per shipment | 1 | $191 | 0.0% |
| 10 | GLOBYZ BIOPHARMA PRIVATE LIMITED Avg $144 per shipment | 1 | $144 | 0.0% |
This table shows the top 10 of 11 Indian companies exporting imatinib to United States, ranked by total trade value. The listed exporters are: EUGIA PHARMA SPECIALITIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, MYGENIC HEALTHCARE PRIVATE LIMITED, KOIT BIOPHARMA PRIVATE LIMITED, ATLAS ENTERPRISES, VEA IMPEX (I) PRIVATE LIMITED, VEA IMPEX I PRIVATE LIMITED, VINAYAK ASSOCIATES, GLOBYZ BIOPHARMA PRIVATE LIMITED. EUGIA PHARMA SPECIALITIES LIMITED is the dominant supplier with 60 shipments worth $4.6M USD, giving it a 85% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Showing top 10 of 11 total Indian exporters on the India to United States Imatinib export route.
Top 10 Imatinib Importers in United States
Showing top 10 of 25 known buyers in United States receiving Imatinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian imatinib in United States include AUROBINDO PHARMA USA INC, AUROBINDO PHARMA USA., INC,, QUALLENT PHARMACEUTICALS HEALTH LLC, AUROBINDO PHARMA USA., INC, SUN PHARMACEUTICAL INDUSTRIES INC, among 25 total buyers. The largest importer is AUROBINDO PHARMA USA INC, accounting for $1.5M USD across 14 shipments — representing 29% of all imatinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA USA INC | 14 | $1.5M | 28.8% |
| 2 | AUROBINDO PHARMA USA., INC, | 13 | $1.2M | 22.4% |
| 3 | QUALLENT PHARMACEUTICALS HEALTH LLC | 12 | $553.2K | 10.4% |
| 4 | AUROBINDO PHARMA USA., INC | 5 | $476.1K | 8.9% |
| 5 | SUN PHARMACEUTICAL INDUSTRIES INC | 14 | $416.6K | 7.8% |
| 6 | AUROLOGISTICS LLC, (AUROBINDO PHARM | 10 | $272.3K | 5.1% |
| 7 | AUROBINDO PHARMA USA INC NA | 3 | $249.5K | 4.7% |
| 8 | SUN PHARMACEUTICAL INDUSTRIES,INC. | 8 | $233.5K | 4.4% |
| 9 | AUROLOGISTICS LLC AUROBINDO PHARM | 2 | $150.3K | 2.8% |
| 10 | AUROLOGISTICS LLC | 1 | $119.1K | 2.2% |
Showing top 10 of 25 Imatinib importers in United States on this route.
Top 10 Imatinib Formulations Imported by United States
Showing top 10 of 80 product formulations shipped on the India to United States Imatinib route, ranked by trade value
United States imports a wide range of imatinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — IMATINIB MESYLATE TABLETS 400 MG IMATIN — accounts for $249.5K USD across 3 shipments. There are 80 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | IMATINIB MESYLATE TABLETS 400 MG IMATIN | 3 | $249.5K | 4.7% |
| 2 | IMATINIB MESYLATE TABLETS 400 MG (IMATINIB MESYLATE TABLETS 400MG 30 S - US) (QTY: 19928 PACKS) | 3 | $245.6K | 4.6% |
| 3 | IMATINIB MESYLATE TABLETS 400 MG - US (30 S COUNT BOTTLE WITH RAYON COIL) (QTY:15460 PACKS) | 1 | $240.6K | 4.5% |
| 4 | IMATINIB Mesylate Tablets 400mg PACK : 30s Bottle Batch No. As Per DOCUMENT | 4 | $228.1K | 4.3% |
| 5 | IMATINIB MESYLATE TABLETS 400 MG IMATINIB MESYLATE TABLETS 400MG 30 S - US QTY: 7023 PACKS | 2 | $218.8K | 4.1% |
| 6 | IMATINIB MESYLATE TABLETS 400 MG (IMATINIB MESYLATE TABLETS 400MG 30 S - US) (QTY: 15702 PACKS)NOS | 3 | $195.8K | 3.7% |
| 7 | IMATINIB MESYLATE TABLETS 400 MG IMATINIB MESYLATE TABLETS 400MG 30 S - US QTY: 15519 PACKS | 1 | $193.7K | 3.6% |
| 8 | IMATINIB MESYLATE TABLETS 400 MG IMATINIB MESYLATE TABLETS 400MG 30 S - US QTY: 7775 PACKS | 2 | $193.5K | 3.6% |
| 9 | IMATINIB MESYLATE TABLETS 400 MG IMATINIB MESYLATE TABLETS 400MG 30 S - US QTY: 15155 PACKS | 1 | $193.0K | 3.6% |
| 10 | IMATINIB MESYLATE TABLETS 400 MG(IMATINIB MESYLATE TABLETS 400 MG-US(30S COUNT BOTTLE WITH RAYON COIL))(QTY:11659 PACKS) | 1 | $176.8K | 3.3% |
Showing top 10 of 80 Imatinib formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 71%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 33 shipments. Transit time averages 25 days by sea.
Market Dynamics
India's imatinib exports to United States are driven primarily by a handful of large-scale manufacturers. EUGIA PHARMA SPECIALITIES LIMITED with 60 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD — together account for 100% of total trade value on this route. The average shipment value of $45.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as imatinib mesylate tablets 400 mg (imatinib mesylate tablets 400mg 30 s - us) (qty: 19928 packs) and imatinib mesylate tablets 400 mg - us (30 s count bottle with rayon coil) (qty:15460 packs), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, AUROBINDO PHARMA USA INC is the largest importer with 14 shipments worth $1.5M USD — representing 29% of all imatinib imports from India on this route. A total of 25 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $5.3M
- Avg. Shipment
- $45.5K
- Suppliers
- 11
- Buyers
- 25
- Transit (Sea)
- ~25 days
- Annual Growth
- +13.9%
Reverse Direction
United States → India — Imatinib (Import)Other Imatinib Routes
Unlock the Full India to United States Imatinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 117 shipments on this route.
Frequently Asked Questions — India to United States Imatinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Imatinib to United States?
The leading Indian exporters of Imatinib to United States are EUGIA PHARMA SPECIALITIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD. EUGIA PHARMA SPECIALITIES LIMITED holds the largest market share at approximately 85% of total trade value on this route.
Q What is the total value of Imatinib exports from India to United States?
India exports Imatinib to United States worth approximately $5.3M USD across 117 recorded shipments. The average value per shipment is $45.5K USD.
Q Which ports does India use to ship Imatinib to United States?
The most active port of origin is SAHAR AIR with 33 shipments. Indian exporters primarily use sea freight for this route, with 71% of shipments going by sea and 19% by air.
Q How long does shipping take from India to United States for Imatinib?
The average transit time for Imatinib shipments from India to United States is approximately 25 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Imatinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 13.9% with demand growth tracking at 14.0%. The route is ranked #20 among India's top Imatinib export destinations globally.
Q How many suppliers are active on the India to United States Imatinib route?
There are currently 11 active Indian suppliers exporting Imatinib to United States. The market is moderately concentrated with EUGIA PHARMA SPECIALITIES LIMITED accounting for 85% of total shipment value.
Q Who are the main importers of Imatinib from India in United States?
The leading importers of Indian Imatinib in United States include AUROBINDO PHARMA USA INC, AUROBINDO PHARMA USA., INC,, QUALLENT PHARMACEUTICALS HEALTH LLC, AUROBINDO PHARMA USA., INC, SUN PHARMACEUTICAL INDUSTRIES INC. AUROBINDO PHARMA USA INC is the largest buyer with 14 shipments worth $1.5M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Imatinib.
- 2.Supplier/Buyer Matching: 11 Indian exporters and 25 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 117 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
117 Verified Shipments
11 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists